183 related articles for article (PubMed ID: 26021727)
1. Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders.
Jaiswal P; Mohanakumar KP; Rajamma U
Neurosci Biobehav Rev; 2015 Aug; 55():413-31. PubMed ID: 26021727
[TBL] [Abstract][Full Text] [Related]
2. Toward an immune-mediated subtype of autism spectrum disorder.
McDougle CJ; Landino SM; Vahabzadeh A; O'Rourke J; Zurcher NR; Finger BC; Palumbo ML; Helt J; Mullett JE; Hooker JM; Carlezon WA
Brain Res; 2015 Aug; 1617():72-92. PubMed ID: 25445995
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.
Margolis KG; Li Z; Stevanovic K; Saurman V; Israelyan N; Anderson GM; Snyder I; Veenstra-VanderWeele J; Blakely RD; Gershon MD
J Clin Invest; 2016 Jun; 126(6):2221-35. PubMed ID: 27111230
[TBL] [Abstract][Full Text] [Related]
4. Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial.
Wong NM; Dipasquale O; Turkheimer F; Findon JL; Wichers RH; Dimitrov M; Murphy CM; Stoencheva V; Robertson DM; Murphy DG; Daly E; McAlonan GM
J Psychopharmacol; 2022 Jun; 36(6):723-731. PubMed ID: 35491679
[TBL] [Abstract][Full Text] [Related]
5. Brain hyperserotonemia causes autism-relevant social deficits in mice.
Tanaka M; Sato A; Kasai S; Hagino Y; Kotajima-Murakami H; Kashii H; Takamatsu Y; Nishito Y; Inagaki M; Mizuguchi M; Hall FS; Uhl GR; Murphy D; Sora I; Ikeda K
Mol Autism; 2018; 9():60. PubMed ID: 30498565
[TBL] [Abstract][Full Text] [Related]
6. The influence of neuroinflammation in Autism Spectrum Disorder.
Matta SM; Hill-Yardin EL; Crack PJ
Brain Behav Immun; 2019 Jul; 79():75-90. PubMed ID: 31029798
[TBL] [Abstract][Full Text] [Related]
7. SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population.
Jaiswal P; Guhathakurta S; Singh AS; Verma D; Pandey M; Varghese M; Sinha S; Ghosh S; Mohanakumar KP; Rajamma U
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():196-206. PubMed ID: 25261775
[TBL] [Abstract][Full Text] [Related]
8. Role of the Immune System in Autism Spectrum Disorders (ASD).
Ormstad H; Bryn V; Saugstad OD; Skjeldal O; Maes M
CNS Neurol Disord Drug Targets; 2018; 17(7):489-495. PubMed ID: 29984670
[TBL] [Abstract][Full Text] [Related]
9. Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders.
Israelyan N; Margolis KG
Pharmacol Res; 2018 Jun; 132():1-6. PubMed ID: 29614380
[TBL] [Abstract][Full Text] [Related]
10. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
[TBL] [Abstract][Full Text] [Related]
11. Serotonin abnormalities in Engrailed-2 knockout mice: New insight relevant for a model of Autism Spectrum Disorder.
Viaggi C; Gerace C; Pardini C; Corsini GU; Vaglini F
Neurochem Int; 2015 Aug; 87():34-42. PubMed ID: 26002543
[TBL] [Abstract][Full Text] [Related]
12. The serotonin system in autism spectrum disorder: From biomarker to animal models.
Muller CL; Anacker AMJ; Veenstra-VanderWeele J
Neuroscience; 2016 May; 321():24-41. PubMed ID: 26577932
[TBL] [Abstract][Full Text] [Related]
13. The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder.
Masi A; Glozier N; Dale R; Guastella AJ
Neurosci Bull; 2017 Apr; 33(2):194-204. PubMed ID: 28238116
[TBL] [Abstract][Full Text] [Related]
14. Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder.
Yoshimura Y; Kikuchi M; Saito DN; Hirosawa T; Takahashi T; Munesue T; Kosaka H; Naito N; Ouchi Y; Minabe Y
Sci Rep; 2020 Sep; 10(1):14558. PubMed ID: 32883965
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of gut-immune-brain mechanisms in Autism Spectrum Disorder.
Azhari A; Azizan F; Esposito G
Dev Psychobiol; 2019 Jul; 61(5):752-771. PubMed ID: 30523646
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder.
Hirosawa T; Kikuchi M; Ouchi Y; Takahashi T; Yoshimura Y; Kosaka H; Furutani N; Hiraishi H; Fukai M; Yokokura M; Yoshikawa E; Bunai T; Minabe Y
Autism Res; 2017 May; 10(5):821-828. PubMed ID: 28266806
[TBL] [Abstract][Full Text] [Related]
17. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
Thom RP; Keary CJ; Palumbo ML; Ravichandran CT; Mullett JE; Hazen EP; Neumeyer AM; McDougle CJ
Psychopharmacology (Berl); 2019 Oct; 236(10):3045-3061. PubMed ID: 31139876
[TBL] [Abstract][Full Text] [Related]
18. Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation.
Ohja K; Gozal E; Fahnestock M; Cai L; Cai J; Freedman JH; Switala A; El-Baz A; Barnes GN
Neuromolecular Med; 2018 Jun; 20(2):161-173. PubMed ID: 29691724
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
20. [Serotonergic regulation of the immune system].
Lychkova AÉ; Puzikov AM
Usp Fiziol Nauk; 2014; 45(4):69-88. PubMed ID: 25729845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
